María Motos-Muñoz

Prof. María Motos-Muñoz

Universidad Católica de Valencia San Vicente Mártir

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Jose Enrique de la Rubia Ortí OrtíJose Enrique de la Rubia Ortí Ortí
Jose Enrique de la Rubia Ortí Ortí
CMCostanza Moneti
Costanza Moneti
PSPilar Serrano-Ballesteros
Pilar Serrano-Ballesteros
Gloria CastellanoGloria Castellano
Gloria Castellano
RBRaquel Bayona-Babiloni
Raquel Bayona-Babiloni
María BenllochMaría Benlloch
María Benlloch
Autism Spectrum Disorder (ASD) is characterized by varying degrees of difficulty in social interaction and communication. These deficits are often associated with gastrointestinal symptoms, indicating alterations in both intestinal microbiota composition and metabolic activities. The intestinal microbiota influences the function and development of the nervous system. In individuals with ASD, there is an increase in bacterial genera such as Clostridium, as well as species involved in the synthesis of branched-chain amino acids (BCAA) like Prevotella copri. Conversely, decreased amounts of Akkermansia muciniphila and Bifidobacterium spp. are observed. Epigallocatechin-3-gallate (EGCG) is one of the polyphenols with the greatest beneficial activity on microbial growth, and its consumption is associated with reduced psychological distress. Therefore, the objective of this review is to analyze how EGCG and its metabolites can improve the microbial dysbiosis present in ASD and its impact on the pathology. The analysis reveals that EGCG inhibits the growth of pathogenic bacteria like Clostridium perfringens and Clostridium difficile. Moreover, it increases the abundance of Bifidobacterium spp. and Akkermansia spp. As a result, EGCG demonstrates efficacy in increasing the production of metabolites involved in maintaining epithelial integrity and improving brain function. This identifies EGCG as highly promising for complementary treatment in ASD.

31 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Jose Enrique de la Rubia Ortí OrtíJose Enrique de la Rubia Ortí Ortí
Jose Enrique de la Rubia Ortí Ortí
MCMaría Cuerda-Ballester
María Cuerda-Ballester
EDEraci Drehmer
Eraci Drehmer
SJSandra Carrera Juliá
Sandra Carrera Juliá
MMMaría Motos-Muñoz
María Motos-Muñoz
MLMaria López-Rodríguez
Maria López-Rodríguez
Vitamin B1, or thiamine, is one of the most relevant vitamins in obtaining energy for the nervous system. Thiamine deficiency or lack of activity causes neurological manifestations, especially symptoms of depression, intrinsic to multiple sclerosis (MS) and related to its pathogenesis. On this basis, the aim of this study was to determine the possible relationship between the nutritional habits of patients with MS and the presence of depression. Therefore, a cross-sectional and observational descriptive study was conducted. An analysis of dietary habits and vitamin B1 consumption in a Spanish population of 51 MS patients was performed by recording the frequency of food consumption. Results showed a vitamin B1 intake within the established range, mainly provided by the consumption of ultra-processed products such as cold meats or pastries, and a total carbohydrate consumption lower than recommended, which stands out for its high content of simple carbohydrates deriving from processed foods such as dairy desserts, juice, snacks, pastries, chocolate bars, soft drinks and fermented alcohol. In addition, a significant negative correlation between depression and the intake of thiamine and total carbohydrates was observed. These findings could explain the influence of MS patients’ eating habits, and consequently vitamin B1 activity, on depression levels.

20 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Jose Enrique de la Rubia Ortí OrtíJose Enrique de la Rubia Ortí Ortí
Jose Enrique de la Rubia Ortí Ortí
CMCostanza Moneti
Costanza Moneti
PSPilar Serrano-Ballesteros
Pilar Serrano-Ballesteros
Gloria CastellanoGloria Castellano
Gloria Castellano
RBRaquel Bayona-Babiloni
Raquel Bayona-Babiloni
María BenllochMaría Benlloch
María Benlloch
Autism Spectrum Disorder (ASD) is characterized by varying degrees of difficulty in social interaction and communication. These deficits are often associated with gastrointestinal symptoms, indicating alterations in both intestinal microbiota composition and metabolic activities. The intestinal microbiota influences the function and development of the nervous system. In individuals with ASD, there is an increase in bacterial genera such as Clostridium, as well as species involved in the synthesis of branched-chain amino acids (BCAA) like Prevotella copri. Conversely, decreased amounts of Akkermansia muciniphila, and Bifidobacterium spp. are observed. Epigallocatechin gallate (EGCG) is one of the polyphenols with the greatest beneficial activity on microbial growth and its consumption is associated with reduced psychological distress. Therefore, the objective of this review is to analyze how EGCG and its metabolites can improve the microbial dysbiosis present in ASD and its impact on the pathology. The analysis reveals that EGCG inhibits the growth of pathogenic bacteria like Clostridium perfringens and Clostridium difficile. Moreover, it increases the abundance of Bifidobacterium spp. and Akkermansia spp. As a result, EGCG demonstrates efficacy in increasing the production of metabolites involved in maintaining epithelial integrity and improving brain function. This identifies EGCG as highly promising for complementary treatment in ASD.